Process View
Any process that modulates the frequency, rate or extent of protein ubiquitination involved in ubiquitin-dependent protein catabolic process.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of protein ubiquitination involved in ubiquitin dependent protein catabolic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.788 | ||
| PML | promyelocytic leukemia | 0.544 | ||
| DAXX | death-domain associated protein | 0.426 | ||
| TRIM39 | tripartite motif containing 39 | 0.370 | ||
| MED15 | mediator complex subunit 15 | 0.336 | ||
| ATF5 | activating transcription factor 5 | 0.306 | ||
| RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.280 | ||
| TRIM5 | tripartite motif containing 5 | 0.233 | Human | |
| UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.232 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.225 | Human Mouse | |
| BCL2L1 | BCL2-like 1 | 0.224 | ||
| TP53 | tumor protein p53 | 0.195 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.194 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.174 | ||
| TRIM21 | tripartite motif containing 21 | 0.161 | Human | |
| UBE2D4 | ubiquitin-conjugating enzyme E2D 4 (putative) | 0.158 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.151 | ||
| SRCIN1 | SRC kinase signaling inhibitor 1 | 0.125 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.108 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.104 | ||
| APH1A | anterior pharynx defective 1 homolog A (C. elegans) | 0.104 | ||
| USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.100 | ||
| ARIH2 | ariadne homolog 2 (Drosophila) | 0.098 | ||
| SP100 | SP100 nuclear antigen | 0.098 | ||
| PTPRA | protein tyrosine phosphatase, receptor type, A | 0.091 | ||
| WASL | Wiskott-Aldrich syndrome-like | 0.089 | ||
| CUL1 | cullin 1 | 0.081 | ||
| SYVN1 | synovial apoptosis inhibitor 1, synoviolin | 0.064 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.059 | ||
| RNF5 | ring finger protein 5 | 0.055 | ||
| TRIM32 | tripartite motif containing 32 | 0.050 | ||
| FLNB | filamin B, beta | 0.048 | ||
| PLSCR1 | phospholipid scramblase 1 | 0.048 | ||
| PDCD6IP | programmed cell death 6 interacting protein | 0.045 | ||
| PXN | paxillin | 0.044 | ||
| SFN | stratifin | 0.042 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.042 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.042 | ||
| PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.041 | ||
| DNAJB2 | DnaJ (Hsp40) homolog, subfamily B, member 2 | 0.041 | ||
| BTRC | beta-transducin repeat containing | 0.040 | ||
| SIRT2 | sirtuin 2 | 0.040 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.036 | ||
| PEX26 | peroxisomal biogenesis factor 26 | 0.033 | ||
| CCDC6 | coiled-coil domain containing 6 | 0.030 | ||
| SKP1 | S-phase kinase-associated protein 1 | 0.029 | ||
| MATK | megakaryocyte-associated tyrosine kinase | 0.029 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.028 | ||
| PKP4 | plakophilin 4 | 0.027 | ||
| UBE2D1 | ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast) | 0.026 | ||
| BANP | BTG3 associated nuclear protein | 0.026 | ||
| TRIM43 | tripartite motif containing 43 | 0.025 | ||
| CLTC | clathrin, heavy chain (Hc) | 0.024 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.022 | ||
| CLSPN | claspin | 0.021 | ||
| UBE2U | ubiquitin-conjugating enzyme E2U (putative) | 0.021 | ||
| ACTN2 | actinin, alpha 2 | 0.020 | ||
| PFDN1 | prefoldin subunit 1 | 0.020 | ||
| MAP1A | microtubule-associated protein 1A | 0.019 | ||
| SYNE1 | spectrin repeat containing, nuclear envelope 1 | 0.019 | ||
| USPL1 | ubiquitin specific peptidase like 1 | 0.019 | ||
| TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.017 | ||
| RNF11 | ring finger protein 11 | 0.017 | ||
| MAK | male germ cell-associated kinase | 0.016 | ||
| PRKCA | protein kinase C, alpha | 0.016 | ||
| PIAS4 | protein inhibitor of activated STAT, 4 | 0.015 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.015 | ||
| MAPK7 | mitogen-activated protein kinase 7 | 0.015 | ||
| HDAC6 | histone deacetylase 6 | 0.015 | ||
| ZNF473 | zinc finger protein 473 | 0.014 | ||
| PHF17 | PHD finger protein 17 | 0.014 | ||
| USP4 | ubiquitin specific peptidase 4 (proto-oncogene) | 0.014 | ||
| TOM1L1 | target of myb1 (chicken)-like 1 | 0.014 | ||
| ZNRF1 | zinc and ring finger 1 | 0.014 | ||
| ZFYVE1 | zinc finger, FYVE domain containing 1 | 0.014 | ||
| MMS22L | MMS22-like, DNA repair protein | 0.013 | ||
| MAD2L2 | MAD2 mitotic arrest deficient-like 2 (yeast) | 0.013 | ||
| NMI | N-myc (and STAT) interactor | 0.013 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.013 | ||
| UBE2D3 | ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast) | 0.013 | ||
| CDK4 | cyclin-dependent kinase 4 | 0.012 | ||
| QPRT | quinolinate phosphoribosyltransferase | 0.012 | ||
| FBXW2 | F-box and WD repeat domain containing 2 | 0.011 | ||
| AMFR | autocrine motility factor receptor | 0.011 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.010 | ||
| DNM1 | dynamin 1 | 0.010 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.010 |